close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about OCUL

Recent news which mentions OCUL

< Previous 1 2 3 4 5 Next >
Recap: Ocular Therapeutix Q2 Earnings
Tickers OCUL
Tags OCUL Earnings BZI/Recaps
From Benzinga
Earnings Scheduled For August 8, 2022
Tickers MRSN MX NCMI NE
Tags NYXH TGB PRTY
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers ACB AERI AGIO ALBO
Tags 52 Week Lows IOVA OPTT
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers NRIX NRXP NTNX OCCI
Tags SGHC SNOW OVID
From Benzinga
Expert Ratings for Ocular Therapeutix
Tickers OCUL
Tags BZI/AAR OCUL Analyst Ratings
From Benzinga
Earnings Scheduled For May 9, 2022
Tickers IFF III IIIV ITUB
Tags VTRS SDC IFF
From Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags TEVA SPRO RIGL
From Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Tickers AGTC AMGN AMRN ATHX
Tags SRPT Earnings IPOs
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACON ALNA BLRX CABA
Tags JSPR CABA Market News
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers HLBZ HNST HYFM HYRE
Tags RMBL ITI IIPR
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers ACLX ADVM AFCG ALLK
Tags AMSC CIA FNHC
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Tickers ABT ANTX GSK IBB
Tags Biotech General ANTX
From Benzinga
Recap: Ocular Therapeutix Q4 Earnings
Tickers OCUL
Tags OCUL Benzinga Market News
From Benzinga
Earnings Scheduled For February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags BZI/UE ITCB VRRM
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers LAWS LAZ LII LOVE
Tags NISN LII Movers
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
Tickers OCUL
Tags Movers General Biotech
From Benzinga
3 Small-Cap Stocks to Buy Now and Hold for the Long Haul
Tickers NNOX OCUL RNLX
Tags RNLX OCUL NNOX
From Motley Fool
Expert Ratings For Ocular Therapeutix
Tickers OCUL
Tags Analyst Ratings Benzinga Market News
From Benzinga
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
Tickers OCUL
Tags Small Cap Legal Market News
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ABSI ACAD ASRT CMPS
Tags Intraday Update ASRT Market News
From Benzinga
Ocular Therapeutix: Q3 Earnings Insights
Tickers OCUL
Tags OCUL BZI/Recaps Benzinga
From Benzinga
Earnings Scheduled For November 8, 2021
Tickers GPMT GTES GWRS HIL
Tags Earnings RDNT HLIO
From Benzinga
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
Tickers OCUL
Tags Market News Benzinga Analyst Ratings
From Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
Tickers AVIR BBIG GRTX MTCR
Tags Movers BBIG Trading Ideas
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers BAC BJRI CCL MSFT
Tags TSLA Analyst Ratings WHR
From Benzinga
55 Biggest Movers From Friday
Tickers AGEN ALTM AUPH BBIG
Tags INTC BTCY OLN
From Benzinga
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Tickers AGEN AVIR BMY DWAC
Tags DWAC TSLA SHIB
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop
Tickers AXP CRTD DWAC MTCR
Tags Earnings AXP Mid/Afternoon Market Update
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Tickers AGEN ARAY BFRA BPTS
Tags Markets Top Gainers BFRA
From Benzinga
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
Tickers AXP CRTD DWAC MTCR
Tags PHUN Commodities Markets
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today